Latest Breaking News On - Director bonnie - Page 1 : comparemela.com

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Shares Sold by Johnson Financial Group Inc

Johnson Financial Group Inc. decreased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 22.8% in the fourth quarter, Holdings Channel reports. The firm owned 867 shares of the biopharmaceutical company’s stock after selling 256 shares during the period. Johnson Financial Group Inc.’s holdings in Regeneron Pharmaceuticals were worth $761,000 as of its […]

United statesArthurf ryanBonniel basslerInsider activity at regeneron pharmaceuticalsSecurities exchange commissionNews ratings for regeneron pharmaceuticals dailyMorgan stanleyCriterion capital advisorsBruceg allen investmentsHoldings channelRegeneron pharmaceuticals incRegeneron pharmaceuticals price performanceJohnson financial group incFortitude family officeQuarter for regeneron pharmaceuticalsRegeneron pharmaceuticals

4,031 Shares in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Bought by Apexium Financial LP

4,031 Shares in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Bought by Apexium Financial LP
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJosephj larosaBonniel basslerSutton wealth advisors incRegeneron pharmaceuticals stock performanceQuarter for regeneron pharmaceuticalsCapital management incCantor fitzgeraldExchange commissionSecurities exchange commissionNews ratings for regeneron pharmaceuticals dailyWealth managementMorgan stanleyRegeneron pharmaceuticals company profileEudaimonia advisorsRegeneron pharmaceuticals

Machina Capital S A S Increases Stake in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Machina Capital S A S Increases Stake in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Arthurf ryanBonniel basslerRoyal bankRegeneron pharmaceuticals price performanceCriterion capital advisorsFortitude family officeNews ratings for regeneron pharmaceuticals dailyRegeneron pharmaceuticalsBruceg allen investmentsMorgan stanleyAnnis gardner whiting capital advisorsRegeneron pharmaceuticals company profileSecurities exchange commissionRegeneron pharmaceuticals incQuarter for regeneron pharmaceuticalsFree report

UNIVEST FINANCIAL Corp Has $6 16 Million Stock Position in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

UNIVEST FINANCIAL Corp Has $6 16 Million Stock Position in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Andrewj murphyBonniel basslerRegeneron pharmaceuticalsRegeneron pharmaceuticals company profileMorgan stanleySutton wealth advisors incEudaimonia advisorsNews ratings for regeneron pharmaceuticals dailyCapital management incRegeneron pharmaceuticals incExchange commissionQuarter for regeneron pharmaceuticalsRegeneron pharmaceuticals tradingWealth managementFree reportManagement inc

Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Lowered to Buy at StockNews com

StockNews.com lowered shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a strong-buy rating to a buy rating in a research note released on Tuesday. Other analysts have also recently issued research reports about the stock. TD Cowen increased their price target on shares of Regeneron Pharmaceuticals from $1,020.00 to $1,030.00 and gave the stock […]

Josephj larosaBonniel basslerSanfordc bernsteinCatalina capital groupAnalyst recommendations for regeneron pharmaceuticalsWealth managementRegeneron pharmaceuticals incRegeneron pharmaceuticals stockNews ratings for regeneron pharmaceuticals dailyCantor fitzgeraldRegeneron pharmaceuticalsTeam hewinsRegeneron pharmaceuticals company profileSecurities exchange commissionCsenge advisory groupFree report